| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | EP1397366B1 Novel ligand for nicotinic acetylcholine receptors useful in therapy |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP0998474B1 Piperazine derivatives |
| 02/07/2007 | EP0602112B1 High content ibuprofen agglomerates and process to prepare them |
| 02/07/2007 | CN1910187A Triaza-cyclopenta [cd] indene derivatives |
| 02/07/2007 | CN1910165A Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 02/07/2007 | CN1910157A Derivatives of N'- (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CBI receptor affinity |
| 02/07/2007 | CN1909910A Triterpene compounds which are effective on improvement of brain function |
| 02/07/2007 | CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept |
| 02/07/2007 | CN1909901A A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
| 02/07/2007 | CN1909893A Propofol-containing fat emulsion preparation |
| 02/07/2007 | CN1908146A Sweet fermented rice extract and preparation method and application thereof |
| 02/07/2007 | CN1907974A Huperzine with analgesic function and derivative thereof |
| 02/07/2007 | CN1907959A New crystalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907958A New crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907957A Crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 02/07/2007 | CN1907938A Process for the preparation of (2R)-2-propyloctanoic acid |
| 02/07/2007 | CN1907461A Brain release beverage |
| 02/07/2007 | CN1907453A Pure Chinese traditional medicine oral liquid for drug rehabilitation and preparation method thereof |
| 02/07/2007 | CN1907425A Decoction preparation for treating asomnia and its preparation process |
| 02/07/2007 | CN1907408A Decoction preparation for treating asomnia of qi deficiency and its preparation process |
| 02/07/2007 | CN1907407A Decoction preparation for treating obstinate asomnia and its preparation process |
| 02/07/2007 | CN1907406A Decoction preparation for treating asomnia of protracted disease intruding into collateral and its preparation process |
| 02/07/2007 | CN1907404A Medicine for treating mental disorder |
| 02/07/2007 | CN1907344A Feet soak medicine for treating insomnia and its preparation method |
| 02/07/2007 | CN1907326A Drug for treating neurous system diseases, cardiovascular and cerebrovascular diseases, and neuropathic pain |
| 02/07/2007 | CN1907290A Nose cavity administering formulation of gastrodine |
| 02/07/2007 | CN1907287A Beta-amyloid peptide inhibitor and screen method thereof |
| 02/07/2007 | CN1907271A Selegilne and/or chlorhydric acid selegilne paste matrix and preparation method for said paste |
| 02/07/2007 | CN1907268A Sertraline salts and sustained-release dosage forms of sertraline |
| 02/07/2007 | CN1298719C Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 02/07/2007 | CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298713C Process for the preparation of 5-substituted isobenzofurans |
| 02/07/2007 | CN1298709C Thiophene-and thiazolesulfonamides as antineoplastic agents |
| 02/07/2007 | CN1298708C Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
| 02/07/2007 | CN1298374C Chinese medicine for giving up drugs |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298316C Pharma ceutical formulation containing LTB4 antagonist |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 02/06/2007 | US7173018 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172876 Method of screening therapeutic agents for nerve degeneration associated diseases |
| 02/06/2007 | US7172871 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172767 Opioid agonist / antagonist combinations |
| 02/06/2007 | US7172763 Post-operative pain treatment by peripheral administration of a neurotoxin |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2274103C Methods of treating mental diseases, inflammation and pain |
| 02/06/2007 | CA2258662C Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 02/06/2007 | CA2173207C Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility |
| 02/01/2007 | WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 02/01/2007 | WO2007013936A2 Method for treating nervous system disorders and conditions |
| 02/01/2007 | WO2007013830A1 Nitrocatechol derivatives as comt inhibitors |
| 02/01/2007 | WO2007013824A1 Biologically active extracts from stephania brachyandra |
| 02/01/2007 | WO2007013581A1 Sedative composition |
| 02/01/2007 | WO2007013522A1 Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
| 02/01/2007 | WO2007013421A1 Novel nitrogenated heterocyclic compound |
| 02/01/2007 | WO2007012900A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | WO2007012870A2 Use of nefopam for the treatment of affective disorders |
| 02/01/2007 | WO2007012837A2 Compositions for treating psychiatric conditions |
| 02/01/2007 | WO2007012762A1 Novel polysubstituted 1,1-pyridinyloxycyclopropanamine compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/01/2007 | WO2007012761A1 Novel polysubstituted 1,1-pyridinyl aminocyclopropanamine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 02/01/2007 | WO2007012579A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 02/01/2007 | WO2007012439A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 02/01/2007 | WO2007012276A1 A medicine for abstaining from addiction to drugs and process thereof |
| 02/01/2007 | WO2006132811A3 Ampa receptor potentiators |
| 02/01/2007 | WO2006116630A3 Method for use of acetyl-l-carnitine ( alcar) for treatment of depressive disorders in humans |
| 02/01/2007 | WO2006108689A3 Process for preparing bicyclic compounds |
| 02/01/2007 | WO2006097744A3 Phenol derivatives and their use to modulate pkb activity |
| 02/01/2007 | WO2006088814A3 Dosage form and method for sustained release of a substituted pyrazine compound |
| 02/01/2007 | WO2005063745A9 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
| 02/01/2007 | US20070027192 N-{[1-(Methylamino)cyclopropyl]methyl}pyridin-3-amine dihydrochloride; treatment of neuropathologies associated with cerebral ageing, of mood disorders, of pain and of tobacco withdrawal; selective nicotinic ligands of the central receptor sub-type alpha 4 beta 2 |
| 02/01/2007 | US20070027189 Use of known active ingredients as radical scavengers |